SPARTAN Group

Spondyloarthritis Research and Treatment Network

  • Become a Member
  • Donate
  • Contact Us
  • Home
  • About Us
    • About Spondyloarthritis
    • About SPARTAN
    • Leadership
    • Committees
    • Awards
    • Bylaws
  • Membership
    • Become a Member
    • Corporate Membership
    • Member Directory
  • Annual Meeting
    • 2020 SPARTAN Annual Meeting
    • Meeting Expense Reimbursement
  • Projects
    • CLASSIC Study
  • Grants
    • Fellowship Grants for Pilot Projects
    • Seed Grants for Junior Faculty
  • Publications
    • SPARTAN Newsletter Archive
    • Treatment Guidelines

About Spondyloarthritis

Spondyloarthritis is an inflammatory arthritis that affects the axial, or central, skeleton. The back pain of spondyloarthritis tends to improve with activity and worsen with rest. It shares a genetic overlap with skin psoriasis, inflammatory bowel disease, and inflammatory eye disease. As a result, individuals with spondyloarthritis are more likely to have these conditions, as well as arthritis of smaller joints and irritations of tendons and connective tissue (such as plantar fasciitis).

The disease typically begins before the age of 40 and has a hereditary component, meaning that spondyloarthritis can afflict multiple family members. The diagnosis is made by considering a person’s medical history, the pattern of their symptoms, x-rays and/or magnetic resonance imaging. Blood markers of inflammation and a genetic test called HLA-B27 may help clarify the diagnosis, though these tests are imprecise and as a result do not confirm the diagnosis.

 

About US

About SPARTAN
Leadership
Committees
ByLaws

Sign Up for Our Newsetter

Receive the SPARTAN email newsletter, published quarterly.

Contact Us

SPARTAN Office
PO Box 55491
Portland, OR 97238

Copyright © 2019 · Enterprise Pro (Spartan Child) on Genesis Framework · WordPress · Log in